Comparative Pharmacology
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus OSMITROL 15 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OSMITROL 10 IN WATER versus OSMITROL 15 IN WATER IN PLASTIC CONTAINER.
OSMITROL 10% IN WATER vs OSMITROL 15% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal blood flow, thereby enhancing water excretion.
Osmotically active agent that increases plasma osmolality, drawing water from intracellular and interstitial spaces into the vascular compartment, thereby reducing cerebral edema and intraocular pressure.
0.25-2 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours as needed. Maximum dose: 2 g/kg per dose or 200 g daily.
1.5-2 g/kg intravenous infusion over 30-60 minutes every 6-8 hours as needed for reduction of intracranial pressure or cerebral edema.
None Documented
None Documented
Terminal elimination half-life is approximately 0.25–1.5 hours in patients with normal renal function, prolonged in renal impairment.
Terminal half-life: 0.25–1.5 hours (15–90 minutes) in normal renal function; prolonged to 24–36 hours in anuria or severe renal impairment.
Renal: >90% excreted unchanged by glomerular filtration with minimal tubular reabsorption. Negligible biliary/fecal elimination.
Renal: >90% unchanged by glomerular filtration; minimal tubular reabsorption or secretion. <10% metabolized in liver (negligible).
Category C
Category C
Osmotic Diuretic
Osmotic Diuretic